ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,142.80
      0.97%
      Dow Jones
      38,085.80
      0.00%
      Brent Oil
      88.475
      0.37%
      Bitcoin
      64,355.99
      -0.20%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Nurix Therapeutics Inc (NRIX)

      7. Nurix Therapeutics Inc (NRIX) News

      NRIX Nurix Therapeutics Inc

      12.36
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:10:35
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Nurix Therapeutics Inc NRIX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 12.36 07:10:35
      Open Price Low Price High Price Close Price Prev Close
      12.36
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/16/202418:21GLOBENurix Therapeutics Announces Closing of Public Offering and..
      4/11/202423:38GLOBENurix Therapeutics Announces Pricing of Upsized $175.0..
      4/11/202416:00GLOBENurix Therapeutics Announces Proposed Public Offering
      4/10/202407:00GLOBENurix Therapeutics Reports First Quarter Fiscal 2024..
      4/09/202413:15GLOBENurix Therapeutics Reports First Clinical Evidence of CNS..
      4/09/202407:00GLOBENurix Therapeutics Announces Extension of Strategic..
      4/03/202407:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
      4/02/202407:00GLOBENurix Therapeutics Announces Extension of Strategic..
      3/25/202407:00GLOBENurix Therapeutics is Part of a Team of International..
      3/20/202409:40GLOBENurix Presents the Discovery and Chemical Structure of..
      3/11/202407:02EDGAR2Form 8-K - Current report
      3/11/202407:00GLOBENurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
      3/06/202416:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
      3/05/202416:30GLOBENurix Therapeutics Announces Presentations at the American..
      2/16/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202416:22EDGAR2Form 144 - Report of proposed sale of securities
      2/15/202416:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/15/202416:01EDGAR2Form 8-K - Current report
      2/15/202416:00GLOBENurix Therapeutics Reports Fourth Quarter and Fiscal Year..
      2/15/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202408:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/01/202416:01GLOBENurix Therapeutics Announces Publication in the Journal..
      1/30/202418:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/30/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/30/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/29/202416:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/16/202416:48DJNNurix Therapeutics Gets FDA Fast-Track Designation for..
      1/16/202416:01GLOBENurix Therapeutics Receives U.S. FDA Fast Track Designation..
      1/08/202407:03EDGAR2Form 8-K - Current report
      1/08/202407:00GLOBENurix Therapeutics Outlines 2024 Strategic Priorities with..
      1/02/202416:01GLOBENurix Therapeutics to Present at 42nd Annual J.P. Morgan..
      12/21/202317:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202316:19EDGAR2Form 144 - Report of proposed sale of securities
      12/13/202316:32GLOBEJudith A. Reinsdorf and Katherine M. Sandstrom Named to Toll..
      12/11/202312:03EDGAR2Form 8-K - Current report
      12/11/202312:00GLOBENurix Therapeutics Presents Positive Clinical Data from Its..
      12/04/202316:01GLOBENurix Therapeutics Announces Webcast To Review Data from Its..
      11/13/202307:01EDGAR2Form 8-K - Current report
      11/07/202316:01GLOBENurix Therapeutics to Participate in Upcoming Investor..
      11/02/202309:00GLOBENurix Therapeutics Announces Presentations at the 65th..
      11/01/202317:16DJNNurix Therapeutics Says FDA Places Partial Clinical Hold on..
      11/01/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202316:02EDGAR2Form 8-K - Current report
      11/01/202316:01GLOBENurix Therapeutics Announces Partial Clinical Hold For..
      10/12/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      Your Recent History

      NASDAQ
      NRIX
      Nurix Therapeutics
      Delayed Upgrade Clock